IPCA LABORATORIES
Sector : Pharmaceuticals and health care | Midcap | BSE
Here's the live share price of Ipca Laboratories along with daily highs, lows, percentage changes and volume trends, and, all financial information.
5.01₹ 67
As on Sep 19, 2025, 4:01 PM IST
Ipca Laboratories Price Performance
Today's LowToday's High
₹1,333.55₹1,507.95
₹1,405.00
52 Weeks' Low52 Weeks' High
₹1,200.00₹1,757.65
₹1,405.00
Open Price
₹1,345.00
Prev. Close
₹1,338.00
Volume
30,651
Over the last 5 years, the share price of Ipca Laboratories has gained 6.17% CAGR. Over the past year, the corresponding return has been -3.35%.
Ipca Laboratories’s current P/E of 45.78x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.
Ipca Laboratories Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Ipca Laboratories | 6.86 | 1.39 | 3.24 | 3.63 | -3.35 | 17.89 | 6.17 |
| Sun Pharmaceutical Industries | 2.46 | 1.83 | 0.53 | -4.47 | -10.31 | 23.72 | 26.88 |
| Divi's Laboratories | 2.72 | 1.77 | -4.66 | 6.42 | 13.89 | 19.59 | 14.40 |
| Cipla | 0.10 | 1.71 | 6.22 | 5.14 | -3.85 | 15.04 | 15.46 |
| Torrent Pharmaceuticals | 2.14 | -0.21 | 14.98 | 14.09 | 8.71 | 35.04 | 21.92 |
| Dr. Reddy's Laboratories | 0.55 | 6.29 | -0.21 | 12.94 | 1.71 | 17.31 | 5.19 |
| Mankind Pharma | 3.11 | 6.77 | 14.52 | 23.06 | 9.42 | 23.16 | 13.31 |
| Zydus Lifesciences | -0.75 | 4.85 | 9.18 | 14.01 | -1.65 | 42.32 | 21.23 |
| Lupin | 0.75 | 4.56 | 6.49 | -0.13 | -5.17 | 47.48 | 14.61 |
| Alkem Laboratories | 2.04 | 3.13 | 16.34 | 14.54 | -9.45 | 19.64 | 14.17 |
| Aurobindo Pharma | 2.17 | 2.57 | 3.24 | -3.89 | -26.78 | 29.10 | 7.17 |
| Abbott India | -1.82 | -8.05 | -1.97 | 0.22 | 8.72 | 20.47 | 13.85 |
| Glenmark Pharmaceuticals | -2.16 | 7.13 | 27.12 | 40.23 | 26.25 | 77.84 | 34.53 |
| Laurus Labs | 4.19 | 5.51 | 44.52 | 54.04 | 98.51 | 22.52 | 26.75 |
| Biocon | 1.26 | 1.57 | 6.05 | 8.19 | 2.48 | 8.42 | -2.92 |
| Anthem Biosciences | 1.98 | 3.87 | 16.36 | 16.36 | 16.36 | 5.18 | 3.08 |
| GlaxoSmithKline Pharmaceuticals | -1.38 | -2.86 | -14.32 | -3.47 | 1.40 | 24.71 | 10.06 |
| Cohance Lifesciences | -7.40 | -1.19 | -8.09 | -21.72 | -22.85 | 25.51 | 19.13 |
| Gland Pharma | 0.04 | 3.93 | 18.34 | 27.73 | 11.67 | -3.43 | 2.12 |
| Ajanta Pharma | -1.07 | -5.76 | 0.27 | -2.77 | -20.40 | 26.20 | 19.22 |
Over the last one year, Ipca Laboratories has declined 3.35% compared to peers like Sun Pharmaceutical Industries (-10.31%), Divi's Laboratories (13.89%), Cipla (-3.85%). From a 5 year perspective, Ipca Laboratories has underperformed peers relative to Sun Pharmaceutical Industries (26.88%) and Divi's Laboratories (14.40%).
Ipca Laboratories Financials
Ipca Laboratories Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 1,311.7 | 1,321.6 |
| 10 | 1,318.43 | 1,326.1 |
| 20 | 1,352.36 | 1,343.92 |
| 50 | 1,406.12 | 1,376.57 |
| 100 | 1,401.17 | 1,397.25 |
| 200 | 1,441.71 | 1,404.83 |
Ipca Laboratories Share Holding Pattern
In the latest quarter, Ipca Laboratories remained same as its previous close in promoter holding, while DII stake increased to 36.20%, FII holding fell to 10.67%, and public shareholding moved down to 8.41% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Ipca Laboratories Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| HDFC Mid-Cap Opportunities Fund - Regular Plan | 1,76,34,911 | 2.94 | 2,441.38 |
| Kotak Emerging Equity Fund - Regular Plan | 1,20,05,038 | 2.92 | 1,661.98 |
| DSP Mid Cap Fund | 46,37,728 | 3.37 | 642.05 |
| Nippon India Growth Fund | 31,00,000 | 1.12 | 429.16 |
| Kotak Equity Opportunities Fund - Regular Plan | 25,10,000 | 1.26 | 347.48 |
| HDFC Balanced Advantage Fund - Regular Plan | 24,97,123 | 0.34 | 345.7 |
| DSP Small Cap Fund | 23,20,000 | 1.93 | 321.18 |
| DSP Equity Opportunities Fund | 19,26,482 | 1.74 | 266.7 |
| DSP ELSS Tax Saver Fund | 18,57,399 | 1.56 | 257.14 |
| Axis Midcap Fund | 17,81,240 | 0.79 | 246.59 |
Ipca Laboratories Futures
| Price | (%) As on Invalid Date IST |
| Open Interest | (%) |
| High | |
| Low | |
| Open | |
| Close | |
| Contract Traded | |
| Turnover (in lakhs) |
Ipca Laboratories Options
Ipca Laboratories Corporate Actions
Date Time | Announcement |
|---|---|
| Sep 10, 2025, 11:12 PM IST | Ipca Laboratorie - Relodgement Of Transfer Request For Physical Shares |
| Aug 14, 2025, 9:47 PM IST | Ipca Laboratorie - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
| Aug 12, 2025, 10:49 PM IST | Ipca Laboratorie - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
| Aug 12, 2025, 5:14 PM IST | Ipca Laboratorie - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report |
| Aug 11, 2025, 11:17 PM IST | Ipca Laboratorie - Shareholder Meeting / Postal Ballot-Outcome of AGM |
About Ipca Laboratories
Ipca Laboratories Ltd. is a Public Limited Listed company incorporated on 19/10/1949 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24239MH1949PLC007837 and registration number is 007837. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 6677.92 Cr. and Equity Capital is Rs. 25.37 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- Address48, Kandivli Industrial Estate, Kandivli (West), Mumbai Maharashtra 400067
- Contact
Management
- Mr. Premchand GodhaExecutive Chairman
- Mr. Ajit Kumar JainManaging Director & CFO
- Mr. Pranay GodhaManaging Director & CEO
- Mr. Prashant GodhaExecutive Director
- Dr.(Ms.) Swati PatankarIndependent Director
- Dr. Narendra MairpadyIndependent Director
- Mr. Vivek ShiralkarIndependent Director
- Mr. Kamal Kishore SethIndependent Director
FAQs on Ipca Laboratories Share Price
What is the share price of Ipca Laboratories?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Ipca Laboratories is ₹1,405.00 as on Sep 19, 2025.
What kind of stock is Ipca Laboratories?
The Ipca Laboratories is operating in the Pharmaceuticals and health care Sector. It is classified as a Midcap stock on the BSE.
What is the Market Cap of Ipca Laboratories?
The market cap of Ipca Laboratories is ₹35,645.44 Cr as on Sep 19, 2025.
What are today's High and Low prices of Ipca Laboratories?
Today’s highest and lowest price of Ipca Laboratories are ₹1,507.95 and ₹1,333.55.
What are the 52 Week High and 52 Week Low of Ipca Laboratories?
The 52-week high/low is the highest and lowest price at which Ipca Laboratories stock has traded in the past 52-week or nearly a year. The 52-week high of Ipca Laboratories is ₹1,757.65 and 52-week low of Ipca Laboratories is ₹1,200.00 as on Sep 19, 2025.
How has the Ipca Laboratories performed historically in terms of returns?
The Ipca Laboratories has shown returns of 5.01% over the past day, 1.39% for the past month, 3.24% over 3 months, -3.35% over 1 year, 17.89% across 3 years, and 6.17% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Ipca Laboratories?
P/E ratio of and PB ratio of Ipca Laboratories are 45.78 and 5.13 on Sep 19, 2025. While the company gives a dividend yield of 0.28 per annum.
Trending In Market
Stock Screener
Mutual Funds
IPO’s Open and Upcoming
Top Indices Performance
Stock Market Stats
Gold Rate Today
NSE Top Gainers
NSE Top Losers
BSE Top Gainers
BSE Top Losers
NSE 52-Week High
NSE 52-Week Low
BSE 52-Week High
BSE 52-Week Low
NSE Price Shocker
NSE Volume Shocker
BSE Price Shocker
BSE Volume Shocker
NSE Buyers
NSE Sellers
BSE Buyers
BSE Sellers
Silver Rate Today
Petrol Rate Today
Diesel Rate Today
✕
Market Data